Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare Extends Offer for Clarient Shares

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare has extended its previously announced offer to acquire all of the outstanding stock of Clarient until midnight, New York City time, on Dec. 16, 2010.

GE launched the $580 million acquisition offer for the molecular diagnostics and imaging firm in early November. The offer was scheduled to expire yesterday at midnight, but the offer was extended so investors can consider revised disclosures in a US Securities and Exchange Commission document related to the terms of a settlement with shareholders.

Following the announcement of the acquisition in late October, several shareholder lawsuits were filed against Clarient alleging that members of the firm's board of directors had breached their fiduciary duties. According to Clareint's filing with the SEC last week, the suits also alleged that the merger agreement involved "an unfair price, an inadequate sales process, unreasonable deal protection devices, and that defendants agreed to the merger to benefit themselves personally."

On Friday, Clarient entered into a memorandum of understanding with the shareholders to settle the litigation.

As of 5:00 PM on Dec. 2, approximately 48 percent of Clarient's outstanding common shares had been tendered.

The Scan

Bit of Each

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.